Status:
TERMINATED
Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)
Lead Sponsor:
David H. Barad
Conditions:
Premature Ovarian Failure
Eligibility:
FEMALE
21-39 years
Phase:
PHASE2
PHASE3
Brief Summary
The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with open tubes, fertile male partners and evidence of premature ovarian failure.
Detailed Description
Recruitment: * New patients presenting for Donor egg cycles * Possible print, magazine or Radio advertisement Experimental plan: 1. Informed consent 2. Baseline studies * Antral follicle counts...
Eligibility Criteria
Inclusion
- \>= 1 year of infertility
- \>21 and \<40 years old
- Normal HSG
- Normal Semen analysis (Count \>= 20 million/ motility \> 50%/ Kruger morph \> 14%.
- Absent menses
- Willingness to sign informed consent for study randomization
- Willingness to participate in 3 months of treatment.
Exclusion
- Abnormal semen analysis
- Abnormal HSG
- Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia
- Family history of significant genetic disease, or factor V leiden thrombophilia
- Inability to present for monitoring visits
- Inability to follow medication instruction
- Desire to undergo other fertility treatments before completing three months of this trial
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00948857
Start Date
June 1 2009
End Date
October 1 2011
Last Update
September 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Human Reproduction
New York, New York, United States, 10021